Aclaris Therapeutics, Pediatrix Therapeutics Ink License Deal For ATI-1777 In Greater China

RTTNews | 903 dias atrás
Stocktwits
Aclaris Therapeutics, Pediatrix Therapeutics Ink License Deal For ATI-1777 In Greater China

(RTTNews) - Biopharmaceutical company Aclaris Therapeutics, Inc. (ACRS) and Chinese therapeutic company Pediatrix Therapeutics, Inc. announced that the companies have entered into a license agreement.

Under the license agreement, Aclaris has granted Pediatrix the exclusive rights to develop, manufacture and commercialize ATI-1777, Aclaris' investigational "soft" Janus kinase (JAK) 1/3 inhibitor, for any disease, including atopic dermatitis, in Greater China (Mainland China, Hong Kong, Macau and Taiwan).

Aclaris will retain the rights to develop, manufacture and commercialize ATI-1777 in the rest of the world.

Under the terms of the agreement, Aclaris will receive an upfront payment of $5 million. In addition, Aclaris is eligible to receive milestone payments of up to $91 million if certain development, regulatory and commercial objectives are achieved.

Aclaris is also eligible to receive a tiered royalty ranging from a low-to-high single digit percentage of net sales of ATI-1777 by Pediatrix in Greater China.

For More Such Health News, visit rttnews.com

Etiquetas: ACRS
Stocktwits
read more
Japan Exports Growth Softens On Higher Trade Tariffs

Japan Exports Growth Softens On Higher Trade Tariffs

Japan's exports grew at a slower pace in April largely due to the higher tariffs imposed by the US administration, official data revealed Wednesday. Exports climbed 2.0 percent on a yearly basis in April, slower than the 4.0 percent increase in March, the Ministry of Finance reported. Exports have been rising since last September and the latest growth matched economists' expectations.
RTTNews | 18 minutos atrás
European Shares May Struggle At Open

European Shares May Struggle At Open

European stocks are seen opening little changed on Wednesday, with U.S. fiscal concerns, geopolitical tensions and the Fed outlook likely to be in focus.
RTTNews | 1 h 12 min atrás
European Economic News Preview: UK Inflation Data Due

European Economic News Preview: UK Inflation Data Due

Consumer price data from the UK is the only major report due on Wednesday, headlining a light day for the European economic news. At 2.00 am ET, the Office for National Statistics publishes UK consumer prices for April. Consumer price inflation is forecast to rise to 3.3 percent from 2.6 percent in March.
RTTNews | 1 h 26 min atrás
Sensex, Nifty Marginally Higher In Lackluster Trade

Sensex, Nifty Marginally Higher In Lackluster Trade

Indian shares were modestly higher in early trade on Wednesday, after having suffered heavy losses in the previous session amid rising geopolitical tensions, growing concerns over U.S. debt and a spike in Covid-19 cases in Southeast Asia.
RTTNews | 2 h 40 min atrás
Australian Market Extends Early Gains In Mid-market

Australian Market Extends Early Gains In Mid-market

The Australian stock market is extending its early gains in mid-market moves on Wednesday, adding the gains in the previous session, with the benchmark S&P/ASX 200 staying just below the 8,400 level, despite the broadly negative cues from Wall Street overnight, with gains in mining, financial and energy stocks partially offset by weakness in technology stocks.
RTTNews | 3 h 19 min atrás
Ferramentas
Calendário Económico
Market Hours
Interest Rates
Holidays Calendar
Mercado Forex
Volatilidade Forex
Correlação Forex
Notícias Forex
forex analysis
Dados COT
Liquidez
Calculadoras Forex
Mapa de Calor Forex
Indicators Heatmap
Comunidade
Comunidade
Sistemas
Sistemas Mais Populares
Estratégias
Concursos
Gráficos Forex
Sentimento Forex
Indicador do Outlook
Avaliações
Brokers
Prop Trading Firms
Serviços VPS
Provedores de Sinais
Serviços de Programação EA
Affiliate Programs
Serviços de Corretores PAMM
Serviços de Programa de Descontos
Plataformas de Negociação
Consultores Especialistas
Trocas Crypto
Trading Courses
Brokers
Forex Spreads
Cotações do Corretor Forex
Swaps de Corretor Forex
Volume do Corretor Forex
Promoções Corretor Forex Press Release
Plataforma
Widgets
Recursos
API
RSS
Stock Portfolio
Affiliate Software
Gráficos Avançados
Apoio
FAQ
Ajuda
Contacte-Nos
Reportar um erro!
Sobre
Blog
© 2025 Myfxbook Ltd Todos os Direitos Reservados.
AVISO DE ALTO RISCO: A negociação em moeda estrangeira comporta um alto nível de risco que pode não ser adequado para todos os investidores. A vantagem cria risco adicional e exposição a perdas. Antes de decidir negociar em moeda estrangeira, considere cuidadosamente os seus objetivos de investimento, nível de experiência e tolerância ao risco. Pode perder parte ou todo o seu investimento inicial. Não invista dinheiro que não possa perder. Eduque-se sobre os riscos associados à negociação em moeda estrangeira e procure aconselhamento de um consultor financeiro ou fiscal independente se tiver alguma dúvida. Quaisquer dados e informações são fornecidos apenas para fins informativos e não se destinam a fins comerciais ou de consultoria. O desempenho anterior não é indicativo de resultados futuros.